Tuovinen K (2004)
Organophosphate-induced convulsions and prevention of neuropathological damages
Toxicology 196: 31
Tuovinen K (2004)
Function of plasma and microsomal enzymes in soman toxicity
Drug & Chemical Toxicology 27: 69
Tuovinen K, Hanninen O (1999)
Protection of mice against soman by pretreatment with eptastigmine and physostigmine
Toxicology 139: 233
Tuovinen K, Kaliste-Korhonen E, Raushel FM, Hanninen O (1999)
Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication
Toxicology 134: 169
Kaliste-Korhonen E, Tuovinen K, Hanninen O (1998)
Effect of phenobarbital and beta-naphthoflavone on activities of different rat esterases after paraoxon exposure
General Pharmacology 31: 307
Tuovinen K, Kaliste-Korhonen E, Hanninen O (1997)
Gender differences in activities of mouse esterase and sensitivities to DFP and sarin toxicity
General Pharmacology 29: 333
Kaliste-Korhonen E, Tuovinen K, Hanninen O (1996)
Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro
Hum Exp Toxicol 15: 972
Tuovinen K, Kaliste-Korhonen E, Raushel FM, Hanninen O (1996)
Eptastigmine-phosphotriesterase combination in DFP intoxication
Toxicology & Applied Pharmacology 140: 364
Tuovinen K, Kaliste-Korhonen E, Raushel FM, Hanninen O (1996)
Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication
Toxicology & Applied Pharmacology 141: 555
Tuovinen K, Kaliste-Korhonen E, Raushel FM, Hanninen O (1994)
Phosphotriesterase--a promising candidate for use in detoxification of organophosphates
Fundamental & Applied Toxicology 23: 578